Merit Financial Statements From 2010 to 2025

MMSI Stock  USD 99.95  0.74  0.73%   
Merit Medical financial statements provide useful quarterly and yearly information to potential Merit Medical Systems investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Merit Medical financial statements helps investors assess Merit Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merit Medical's valuation are summarized below:
Gross Profit
643.3 M
Profit Margin
0.0887
Market Capitalization
5.9 B
Enterprise Value Revenue
4.5993
Revenue
1.4 B
We have found one hundred twenty available fundamental ratios for Merit Medical, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Merit Medical last-minute fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The Merit Medical's current Market Cap is estimated to increase to about 3.8 B. The Merit Medical's current Enterprise Value is estimated to increase to about 4 B

Merit Medical Total Revenue

1.42 Billion

Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.5 M, Interest Expense of 32.8 M or Total Revenue of 1.4 B, as well as many indicators such as Price To Sales Ratio of 2.71, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Check out the analysis of Merit Medical Correlation against competitors.

Merit Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.5 B2.4 B1.3 B
Slightly volatile
Short and Long Term Debt Total850.6 M810.1 M377.6 M
Slightly volatile
Other Current Liabilities140.8 M134.1 M76.4 M
Slightly volatile
Total Current Liabilities227.2 M216.4 M137.2 M
Slightly volatile
Total Stockholder Equity1.4 B1.4 B767.3 M
Slightly volatile
Property Plant And Equipment Net474.3 M451.7 M328.1 M
Slightly volatile
Net Debt850.6 M810.1 M316.9 M
Slightly volatile
Non Current Assets Total1.5 B1.5 B892.2 M
Slightly volatile
Net Receivables219.6 M209.2 M123.4 M
Slightly volatile
Common Stock Shares Outstanding40.2 M59.4 M47.5 M
Slightly volatile
Liabilities And Stockholders Equity2.5 B2.4 B1.3 B
Slightly volatile
Non Current Liabilities Total864 M822.8 M414.3 M
Slightly volatile
Inventory321.4 M306.1 M172 M
Slightly volatile
Other Current Assets33.4 M31.8 M16.9 M
Slightly volatile
Total Liabilities1.1 BB551.5 M
Slightly volatile
Property Plant And Equipment Gross843.4 M803.3 M422 M
Slightly volatile
Total Current Assets970 M923.8 M421.6 M
Slightly volatile
Short Term Debt10.5 M10.3 M15.6 M
Slightly volatile
Intangible Assets523.2 M498.3 M258.9 M
Slightly volatile
Cash395.6 M376.7 M109.1 M
Slightly volatile
Cash And Short Term Investments395.6 M376.7 M109.2 M
Slightly volatile
Accounts Payable71.9 M68.5 M44.2 M
Slightly volatile
Non Currrent Assets Other3.4 M3.6 M19.7 M
Slightly volatile
Common Stock Total Equity815.3 M776.5 M426.8 M
Slightly volatile
Common Stock738.4 M703.2 M415.1 M
Slightly volatile
Other Liabilities35.4 M60.3 M52.2 M
Slightly volatile
Other Assets26.4 M44.7 M38.3 M
Slightly volatile
Long Term Debt766 M729.6 M337.2 M
Slightly volatile
Good Will486.7 M463.5 M271.9 M
Slightly volatile
Property Plant Equipment462.4 M440.4 M315 M
Slightly volatile
Current Deferred Revenue3.9 M4.6 M3.1 M
Slightly volatile
Net Tangible Assets614.3 M585 M276.5 M
Slightly volatile
Long Term Debt Total281.4 M214.8 M233.9 M
Slightly volatile
Long Term Investments13.2 M22.8 M10.1 M
Slightly volatile
Non Current Liabilities Other32.7 M17.6 M26.9 M
Slightly volatile
Deferred Long Term Asset Charges1.9 M2.1 M2.2 M
Pretty Stable
Short and Long Term Debt9.4 M10.1 M11.1 M
Very volatile
Net Invested Capital1.6 B2.1 B1.3 B
Slightly volatile
Net Working Capital431.6 M707.4 M310.9 M
Slightly volatile
Capital Stock695 M703.2 M605.5 M
Slightly volatile
Capital Lease Obligations59.3 M65.1 M78.9 M
Slightly volatile

Merit Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization120.5 M114.7 M65.6 M
Slightly volatile
Total Revenue1.4 B1.4 B793.3 M
Slightly volatile
Other Operating Expenses1.3 B1.2 B728.9 M
Slightly volatile
Cost Of Revenue748.8 M713.2 M435.2 M
Slightly volatile
Total Operating Expenses483.6 M460.5 M290.1 M
Slightly volatile
Research Development88 M83.8 M52.7 M
Slightly volatile
Selling General Administrative419.7 M399.7 M240.4 M
Slightly volatile
Non Recurring11.7 M10.2 M12.3 M
Slightly volatile
Interest Income27.5 M26.2 MM
Slightly volatile
Reconciled Depreciation101.1 M114.7 M75.7 M
Slightly volatile

Merit Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow618.6 M589.1 M100 M
Slightly volatile
Depreciation120.5 M114.7 M65.7 M
Slightly volatile
Capital Expenditures29.7 M38 M45.7 M
Very volatile
Total Cash From Operating Activities231.8 M220.8 M97.5 M
Slightly volatile
End Period Cash Flow397.7 M378.8 M109.6 M
Slightly volatile
Stock Based Compensation29.9 M28.5 M9.9 M
Slightly volatile
Change To Netincome30.8 M45.7 M39.8 M
Slightly volatile
Issuance Of Capital Stock38.3 M40.9 M130.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.714.1512.8685
Very volatile
PTB Ratio3.624.08223.2271
Very volatile
Days Sales Outstanding64.5856.280757.8133
Very volatile
Book Value Per Share24.8823.69314.6264
Slightly volatile
Operating Cash Flow Per Share3.983.79261.8429
Slightly volatile
Average PayablesMM4.5 M
Slightly volatile
Stock Based Compensation To Revenue0.0220.0210.0097
Slightly volatile
Capex To Depreciation0.40.421.3341
Slightly volatile
PB Ratio3.624.08223.2271
Very volatile
EV To Sales2.94.74823.2215
Very volatile
Inventory Turnover2.182.33022.8118
Slightly volatile
Days Of Inventory On Hand158157135
Slightly volatile
Payables Turnover7.9410.41119.1239
Slightly volatile
Average Inventory15.9 M18 M19.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.04470.06180.0662
Slightly volatile
Capex To Revenue0.03190.03360.0858
Slightly volatile
Cash Per Share9.679.212.2838
Slightly volatile
POCF Ratio35.5325.502142.5999
Slightly volatile
Capex To Operating Cash Flow0.280.291.2082
Slightly volatile
Days Payables Outstanding44.8135.058745.6513
Slightly volatile
EV To Operating Cash Flow41.3729.171245.9003
Slightly volatile
Intangibles To Total Assets0.420.39770.3795
Slightly volatile
Current Ratio2.484.26882.7357
Slightly volatile
Tangible Book Value Per Share7.537.17274.5342
Slightly volatile
Receivables Turnover5.116.48536.362
Pretty Stable
Graham Number34.8633.197716.168
Slightly volatile
Shareholders Equity Per Share24.8823.69314.6264
Slightly volatile
Debt To Equity0.620.58730.4663
Slightly volatile
Capex Per Share0.50.570.9374
Slightly volatile
Average Receivables11.9 M14.3 M15.4 M
Slightly volatile
Revenue Per Share24.4723.300615.198
Slightly volatile
Interest Debt Per Share15.1714.45157.3478
Slightly volatile
Debt To Assets0.350.3350.2661
Slightly volatile
Short Term Coverage Ratios23.3524.588.4031
Slightly volatile
Operating Cycle222213193
Slightly volatile
Price Book Value Ratio3.624.08223.2271
Very volatile
Days Of Payables Outstanding44.8135.058745.6513
Slightly volatile
Price To Operating Cash Flows Ratio35.5325.502142.5999
Slightly volatile
Company Equity Multiplier1.251.75341.6699
Very volatile
Long Term Debt To Capitalization0.390.3670.2847
Slightly volatile
Total Debt To Capitalization0.390.370.3074
Slightly volatile
Debt Equity Ratio0.620.58730.4663
Slightly volatile
Quick Ratio3.02.85451.7057
Slightly volatile
Dividend Paid And Capex Coverage Ratio3.743.562.0467
Slightly volatile
Net Income Per E B T0.620.80240.888
Pretty Stable
Cash Ratio2.732.60.7303
Slightly volatile
Cash Conversion Cycle180178157
Slightly volatile
Operating Cash Flow Sales Ratio0.170.16280.1123
Slightly volatile
Days Of Inventory Outstanding158157135
Slightly volatile
Days Of Sales Outstanding64.5856.280757.8133
Very volatile
Price To Book Ratio3.624.08223.2271
Very volatile
Fixed Asset Turnover3.213.00332.3985
Slightly volatile
Capital Expenditure Coverage Ratio3.743.562.0467
Slightly volatile
Price Cash Flow Ratio35.5325.502142.5999
Slightly volatile
Debt Ratio0.350.3350.2661
Slightly volatile
Price Sales Ratio2.714.1512.8685
Very volatile
Asset Turnover1.050.56090.6696
Very volatile
Price Fair Value3.624.08223.2271
Very volatile

Merit Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.8 B3.6 B2.5 B
Slightly volatile
Enterprise ValueB3.8 B3.1 B
Slightly volatile

Merit Fundamental Market Drivers

Forward Price Earnings27.027
Cash And Short Term Investments376.7 M

Merit Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue4.6 M3.9 M
Total Revenue1.4 B1.4 B
Cost Of Revenue713.2 M748.8 M
Stock Based Compensation To Revenue 0.02  0.02 
Research And Ddevelopement To Revenue 0.06  0.04 
Capex To Revenue 0.03  0.03 
Revenue Per Share 23.30  24.47 
Ebit Per Revenue 0.11  0.12 

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Earnings Share
2.03
Revenue Per Share
23.301
Quarterly Revenue Growth
0.094
Return On Assets
0.042
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.